Smith & Nephew (CHIX:SNL) 1-Year Share Buyback Ratio : -0.20% (As of Dec. 2024 )

View and export this data going back to 2009. Start your Free Trial

What is Smith & Nephew 1-Year Share Buyback Ratio?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

1-Year Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past year, calculated as the percentage change in shares outstanding from the previous year to the current year. A positive ratio may indicates share buybacks over the period, while a zero or negative ratio suggests no buybacks or potential share issuance. Smith & Nephew's current 1-Year Share Buyback Ratio was -0.20%.

CHIX:SNl's 1-Year Share Buyback Ratio is ranked better than
75.22% of 557 companies
in the Medical Devices & Instruments industry
Industry Median: -2.3 vs CHIX:SNl: -0.20

Competitive Comparison of Smith & Nephew's 1-Year Share Buyback Ratio

For the Medical Devices subindustry, Smith & Nephew's 1-Year Share Buyback Ratio, along with its competitors' market caps and 1-Year Share Buyback Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Smith & Nephew's 1-Year Share Buyback Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Smith & Nephew's 1-Year Share Buyback Ratio distribution charts can be found below:

* The bar in red indicates where Smith & Nephew's 1-Year Share Buyback Ratio falls into.

Save Embed

;

Save Embed

;

Smith & Nephew 1-Year Share Buyback Ratio Calculation

Smith & Nephew's 1-Year Share Buyback Ratio for the quarter that ended in Dec. 2024 is calculated as

1-Year Share Buyback Ratio	=	(Shares Outstanding (EOP) (Dec. 2023 )	-	Shares Outstanding (EOP) (Dec. 2024 ))	/	Shares Outstanding (EOP) (Dec. 2023 )
	=	(871.832	-	873.488)	/	871.832
	=	-0.2%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Smith & Nephew (CHIX:SNl) 1-Year Share Buyback Ratio Explanation

A positive ratio may indicates share buybacks over the period, while a zero or negative ratio suggests no buybacks or potential share issuance.

Be Aware

Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.

Smith & Nephew 1-Year Share Buyback Ratio Related Terms

Smith & Nephew Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Smith & Nephew PLC (CHIX:SNl) » Definitions » 1-Year Share Buyback Ratio

Comparable Companies

Traded in Other Exchanges

SNNUF:USA SNN:USA SN.:UK NPW1:Germany

Address

Hatters Lane, Building 5, Croxley Park, Watford, Hertfordshire, GBR, WD18 8YE

Website

https://www.smith-nephew.com

Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.

Smith & Nephew Headlines

No Headlines